Ajinomoto adds gene therapy to CDMO scope via $554M Forge Bio buyout

The latest stories trending on MedCity News.

Editor's Pick

Top Story Ajinomoto Adds Gene Therapy to CDMO Scope via $554M Forge Bio Buyout Ajinomoto's Forge Biologics acquisition brings contract development and manufacturing organization capabilities in gene therapy. Forge specializes in manufacturing AAV vectors used to deliver these therapies. Sponsored Content Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management Presented by MedCity News & Jorie Healthcare The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It's beginning to attract the attention of major healthcare organizations. Learn More. Heard at HLTH 2023: Altera Digital Health Dr. Mark Pratt, Chief Medical Officer for Altera Digital Health on the partnership with Harris Affinity to help hospitals improve revenue capture and reduce cost.  Watch Now

Featured News

Report: Many Found Renewing Medicaid Coverage Easy, But Some Faced Barriers New KFF focus groups revealed that some thought the process of renewing Medicaid coverage during the unwinding of the continuous enrollment provision was simple. Others, however, faced challenges with communication from state Medicaid agencies, and some weren't aware their coverage had been terminated. Report: Workers Trust Employers More Than Insurers With Their Health Just 37% of employees trust their insurer to suggest high-quality care regardless of cost, while 53% trust their employer with their health, according to a survey released by Included Health. Psychiatry's Future Progress Depends on Innovation, Collaboration, and Access We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds. Novartis to Pay Legend Biotech $100M in Pact Bringing Cell Therapy to Solid Tumors Novartis gains global rights to Legend Biotech cell therapies that address DLL3, a promising target for lung cancers and other types of solid tumors. The pharmaceutical giant may make these therapies using T-Charge, its next-generation CAR T-cell therapy manufacturing technology. Loneliness and its Impact on Alzheimer's Patients: Harnessing Companion Animal Digital Technology A significant healthcare crisis looms as Baby Boomers age, which will contribute to a rise in Alzheimer's cases. Combined with a shortage of geriatricians and caregivers, we will soon have more lonely seniors in America. We must open our minds to new solutions, such as robotic companions. Healthcare Doesn't Need More Big Tech; It Needs Specialized Tech It's easy to oversimplify and say, "These big tech companies are now doing healthcare and they're going to solve everything." But the reality is that often, the solutions are not going to come from big tech.

Resources

MedCity Pivot Podcast: A Conversation with CommonSpirit Health's Population Health Innovation Lead Season 4 of the MedCity Pivot Podcast launches with a focus on health equity and a conversation with Dr. Alisahah Jackson, system vice president of population health innovation and policy at CommonSpirit Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe